Mangalam Organics Limited

rs. 2

@ Manqalam @ oroanits Limited @v Head Office : 812. Tulsiani Chambers. 2'12, Nariman Point, l\ilumbai - 404 421 Tel.:91-22-4920 4089 I 2?82 4089 Fax:91-22-4920 4081 / 2284

rs,

0 a Date: February12,2022 To BSE Limited Listing & Compliance Department Phiroze Jeejeebhoy Towers, Dalal Street, Fort Mumbai - 400001. Security Code: 514418 -b The National Stock Exchange of India

5000 MT

full fledge. Mangalam Organics Ltd. commenced commercial production of additional plant of 5000 MT on 31st January 2022. 5 Our Business Segments B2B- Terpene Revenue break-up • Camphor: Relig

85%

aints, cleaning and degreasing agents • Sodium Acetate: Textile and dyes industry, Leather tanning 85% Terpene Operations B2B - Synthetic Resin • Terpene Phenolic Resin - Adhesives • Alkyl Phenolic

5%

astic compounds for road marking, hot melts and glues susceptible to pressure, insulation finishes 5% Synthetic Resin Operations B2C - Retail Operations • CamPure - Homecare and personal care prod

10%

Camphor • Mangalam - Camphor tablets for pious uses • Private Labelling Initiatives 5% In FY20 10% Retail Operations 6 Our Business Model Chemistry Capabilities B2C Retailing Expertise Com

rs 8

sin Camphor| Dipentene | Sodium Acetate Terpene Phenolic Resin | Alkyl Phenolic Resin | Rosin Esters 8 Our Product Portfolio – B2C Business-to-Consumer CamPure - Homecare and personal care products bas

51%

10 Financials 9M FY22 Consolidated Financial Performance Revenues (Rs. Crs) Revenues (Rs. Crs) +51% 366.4 242.2 EBITDA (Rs. Crs) +4% 79.4 82.3 PAT (Rs. Crs) +1% 51.8 52.4 9M FY21 9M FY22

4%

inancial Performance Revenues (Rs. Crs) Revenues (Rs. Crs) +51% 366.4 242.2 EBITDA (Rs. Crs) +4% 79.4 82.3 PAT (Rs. Crs) +1% 51.8 52.4 9M FY21 9M FY22 9M FY21 9M FY22 9M FY21 9M FY22

1%

Rs. Crs) Revenues (Rs. Crs) +51% 366.4 242.2 EBITDA (Rs. Crs) +4% 79.4 82.3 PAT (Rs. Crs) +1% 51.8 52.4 9M FY21 9M FY22 9M FY21 9M FY22 9M FY21 9M FY22 EBITDA Margin (%) 33% 22% PAT

33%

Rs. Crs) +1% 51.8 52.4 9M FY21 9M FY22 9M FY21 9M FY22 9M FY21 9M FY22 EBITDA Margin (%) 33% 22% PAT Margin (%) 21% 14% 9M FY21 9M FY22 9M FY21 9M FY22 12 Q3 FY22 Consolidated Financ

22%

rs) +1% 51.8 52.4 9M FY21 9M FY22 9M FY21 9M FY22 9M FY21 9M FY22 EBITDA Margin (%) 33% 22% PAT Margin (%) 21% 14% 9M FY21 9M FY22 9M FY21 9M FY22 12 Q3 FY22 Consolidated Financial P